- Home
- FBP vs HAE Comparison
FBP vs HAE Comparison
Compare FBP & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBP
- HAE
- Stock Information
- Founded
- FBP 1948
- HAE 1971
- Country
- FBP United States
- HAE United States
- Employees
- FBP N/A
- HAE N/A
- Industry
- FBP Major Banks
- HAE Medical/Dental Instruments
- Sector
- FBP Finance
- HAE Health Care
- Exchange
- FBP Nasdaq
- HAE Nasdaq
- Market Cap
- FBP 3.4B
- HAE 3.3B
- IPO Year
- FBP N/A
- HAE 1991
- Fundamental
- Price
- FBP $22.26
- HAE $56.36
- Analyst Decision
- FBP Buy
- HAE Buy
- Analyst Count
- FBP 3
- HAE 11
- Target Price
- FBP $24.00
- HAE $86.73
- AVG Volume (30 Days)
- FBP 1.2M
- HAE 1.2M
- Earning Date
- FBP 10-22-2025
- HAE 08-07-2025
- Dividend Yield
- FBP 3.37%
- HAE N/A
- EPS Growth
- FBP 2.67
- HAE 46.89
- EPS
- FBP 1.88
- HAE 3.28
- Revenue
- FBP $890,993,000.00
- HAE $1,346,046,000.00
- Revenue This Year
- FBP $13.22
- HAE N/A
- Revenue Next Year
- FBP $5.71
- HAE $7.26
- P/E Ratio
- FBP $11.38
- HAE $17.19
- Revenue Growth
- FBP 1.81
- HAE 0.91
- 52 Week Low
- FBP $16.40
- HAE $50.68
- 52 Week High
- FBP $22.40
- HAE $94.99
- Technical
- Relative Strength Index (RSI)
- FBP 67.61
- HAE 35.65
- Support Level
- FBP $20.23
- HAE $53.50
- Resistance Level
- FBP $21.51
- HAE $55.00
- Average True Range (ATR)
- FBP 0.36
- HAE 2.94
- MACD
- FBP 0.11
- HAE -0.34
- Stochastic Oscillator
- FBP 95.65
- HAE 21.72
About FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.